{"id":316924,"date":"2026-10-19T14:40:04","date_gmt":"2026-10-19T09:10:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=316924"},"modified":"2026-10-19T14:40:04","modified_gmt":"2026-10-19T09:10:04","slug":"pharma-brand-fermentation-ingredient-maker-and-hotels-to-foods-group-stocks-roadmap-keystone-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharma-brand-fermentation-ingredient-maker-and-hotels-to-foods-group-stocks-roadmap-keystone-list\/","title":{"rendered":"3 Pharma Brand, Fermentation Ingredient Maker and Hotels-to-Foods Group Stocks With a Strong Future Roadmap: Alkem Laboratories, Concord Biotech and ITC"},"content":{"rendered":"

Alkem Rs 5,050.00, P\/E 28.43. Concord Biotech Rs 1,339.00, P\/E 51.00. ITC Rs 263.50, P\/E 15.77. Closing prices of 14 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Pharma brand, fermentation ingredient maker and hotels-to-foods group stocks with the clearest long-term roadmaps today include Alkem in branded generics in India along with generic exports and a presence in international markets, Concord Biotech in fermentation-based active ingredients, including immunosuppressants and anti-infectives and ITC in cigarettes, packaged foods, personal care, paperboards, hotels and agri products. P\/E stands at 28.43 for Alkem (industry 37.59), 51.00 for Concord Biotech (industry 37.59) and 15.77 for ITC (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Pharma brand, fermentation ingredient maker and hotels-to-foods group stocks give investors exposure to medicines, drug ingredients and consumer goods sold across markets. Volumes, pricing and margins decide how much of that demand turns into profit.<\/p>\n

This list covers three pharma brand, fermentation ingredient maker and hotels-to-foods group stocks: Alkem Laboratories for branded generics in India along with generic exports and a presence in international markets, Concord Biotech for fermentation-based active ingredients, including immunosuppressants and anti-infectives and ITC for cigarettes, packaged foods, personal care, paperboards, hotels and agri products. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n